Cargando…
Pandemic-response adenoviral vector and RNA vaccine manufacturing
Rapid global COVID-19 pandemic response by mass vaccination is currently limited by the rate of vaccine manufacturing. This study presents a techno-economic feasibility assessment and comparison of three vaccine production platform technologies deployed during the COVID-19 pandemic: (1) adenovirus-v...
Autores principales: | Kis, Zoltán, Tak, Kyungjae, Ibrahim, Dauda, Papathanasiou, Maria M., Chachuat, Benoît, Shah, Nilay, Kontoravdi, Cleo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891260/ https://www.ncbi.nlm.nih.gov/pubmed/35236838 http://dx.doi.org/10.1038/s41541-022-00447-3 |
Ejemplares similares
-
Optimal design and planning of supply chains for viral vectors and RNA vaccines
por: Ibrahim, Dauda, et al.
Publicado: (2022) -
Model-Based Planning and Delivery of Mass Vaccination Campaigns against Infectious Disease: Application to the COVID-19 Pandemic in the UK
por: Ibrahim, Dauda, et al.
Publicado: (2021) -
Quality by design and techno-economic modelling of RNA vaccine production for pandemic-response
por: Kis, Zoltán, et al.
Publicado: (2022) -
Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand
por: Kis, Zoltán, et al.
Publicado: (2020) -
Correction: Kis, Z. et al. Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand. Vaccines 2021, 9, 3
por: Kis, Zoltán, et al.
Publicado: (2021)